Antiangiogenic effect of oral 2-methoxyestradiol on choroidal neovascularization in mice
Antiangiogenic effect of oral 2-methoxyestradiol on choroidal neovascularization in mice
复制标题
DOI:
10.1016/j.exer.2006.05.016
复制
发表时间:
2006-11-01
影响因子:
3.4
通讯作者:
D'Amato, Robert J.
中科院分区:
文献类型:
--
作者:
Funakoshi, Taisaku;Birsner, Amy E.;D'Amato, Robert J.
We evaluated the efficacy of systemic 2-methoxyestradiol (2ME2) in a laser-induced murime model of choroidal neovascularization (CNV). C57BL/6J mice (8 week old males) were used in this study and divided into four groups. After laser treatment, daily oral treatment with vehicle control, and 30, 50, and 75 mg/kg of 2ME2 was started. Two weeks after laser treatment, digital images of CNV were obtained from fluorescein isothiocyanate-dextran (FITC-dextran) angiography and choroidal flat mount after FITC-dextran perfusion. These images were quantified by NIH image software. Analysis of images from both FITC-dextran angiography and choroidal flat mount with FITC-dextran perfusion demonstrated that the 2ME2 treated groups showed a statistically significant, dose-dependent decrease in CNV. No toxicity or weight loss was observed during the treatment. Significant antiangiogenic effects of oral 2ME2 on laser induced CNV were observed. Since 2ME2 (Panzem (R)) has demonstrated good safety in phase I/II trials for cancer, it has the potential to be used as a novel oral treatment for age-related macular degeneration. (c) 2006 Elsevier Ltd. All rights reserved.